What Intellia Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 3 | 18 |
| Total trades | 3 | 35 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 610,422 |
| Disposed | 24,539 | 213,769 |
| Net activity | −24,539 | +396,653 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Dube Michael P | VP, Chief Accounting Officer | Oct 02 | Open-market sale · S | −1,864 | $12.43 | −$23.2K | 65,022 |
| Leonard John M. | President and CEO | Aug 21 | Open-market sale · S | −2,785 | $13.00 | −$36.2K | 1,147,064 |
| Leonard John M. | President and CEO | Aug 20 | Open-market sale · S | −19,890 | $12.60 | −$251K | 1,149,849 |
| Dulac Edward J Iii | EVP, Chief Financial Officer | Jul 22 | Open-market sale · S | −8,111 | $11.25 | −$91.2K | 148,175 |
| Dulac Edward J Iii | EVP, Chief Financial Officer | Jul 02 | Open-market sale · S | −4,677 | $18.00 | −$84.2K | 156,286 |
| Dube Michael P | VP, Chief Accounting Officer | Jul 01 | Open-market sale · S | −2,641 | $16.78 | −$44.3K | 66,886 |
| Bhanji Muna | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 36,403 |
| Chase William J | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 143,893 |
| Cohen Fred E | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 216,653 |
| Goff Brian | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 32,609 |
| Goodman Jesse | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 33,559 |
| Keresty Georgia | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 41,083 |
| Verwiel Frank | Director | Jun 09 | Grant / award · A | +9,200 | — | — | 35,148 |
| Basta James | EVP, General Counsel | Mar 02 | Open-market sale · S | −1,211 | $13.78 | −$16.7K | 156,794 |
| Clark Eliana | EVP, Chief Technical Officer | Mar 02 | Open-market sale · S | −607 | $13.78 | −$8.36K | 93,864 |
| Dube Michael P | VP, Chief Accounting Officer | Mar 01 | Grant / award · A | +17,250 | — | — | 69,527 |
| Dulac Edward J Iii | EVP, Chief Financial Officer | Mar 01 | Grant / award · A | +61,280 | — | — | 160,963 |
| Leonard John M. | President and CEO | Mar 01 | Grant / award · A | +156,400 | — | — | 1,169,739 |
| Basta James | EVP, General Counsel | Mar 01 | Grant / award · A | +46,080 | — | — | 158,005 |
| Clark Eliana | EVP, Chief Technical Officer | Mar 01 | Grant / award · A | +7,353 | — | — | 94,471 |
Loading...
